RU96117516A - METHOD FOR TREATING PRE- AND PROLIFERATIVE DIABETIC RETINOPATHY - Google Patents

METHOD FOR TREATING PRE- AND PROLIFERATIVE DIABETIC RETINOPATHY

Info

Publication number
RU96117516A
RU96117516A RU96117516/14A RU96117516A RU96117516A RU 96117516 A RU96117516 A RU 96117516A RU 96117516/14 A RU96117516/14 A RU 96117516/14A RU 96117516 A RU96117516 A RU 96117516A RU 96117516 A RU96117516 A RU 96117516A
Authority
RU
Russia
Prior art keywords
diabetic retinopathy
proliferative diabetic
treating pre
treating
proliferative
Prior art date
Application number
RU96117516/14A
Other languages
Russian (ru)
Inventor
Е.Л. Сорокин
Г.П. Смолякова
В.В. Егоров
Original Assignee
Хабаровский филиал МНТК "Микрохирургия глаза"
Filing date
Publication date
Application filed by Хабаровский филиал МНТК "Микрохирургия глаза" filed Critical Хабаровский филиал МНТК "Микрохирургия глаза"
Publication of RU96117516A publication Critical patent/RU96117516A/en

Links

Claims (1)

Способ лечения пре- и пролиферативной диабетической ретинопатии, состоящий в проведении панретинальной аргонлазеркоагуляции сетчатки и отличающийся тем, что за 10 - 15 дней перед ее проведением больному назначается внутривенно 0,03%-ный раствор гипохлорита натрия по 450 мл ежедневно - 4 - 6 на курс.A method of treating pre- and proliferative diabetic retinopathy, which consists in carrying out panretinal argonlasercoagulation of the retina and characterized in that for 10 to 15 days before it is administered, the patient is given an intravenous 0.03% solution of sodium hypochlorite 450 ml daily - 4-6 per course .
RU96117516/14A 1996-09-03 METHOD FOR TREATING PRE- AND PROLIFERATIVE DIABETIC RETINOPATHY RU96117516A (en)

Publications (1)

Publication Number Publication Date
RU96117516A true RU96117516A (en) 1997-11-20

Family

ID=

Similar Documents

Publication Publication Date Title
ATE241378T1 (en) COMBINATIONS OF VASOPRESSIN AND ADRENERGIC ACTIVES FOR THE TREATMENT OF SUDDEN CARDIAC DEATH
PL340096A1 (en) Methods of treating hypercoagulability states or hypoproteinaemia in respect to c protein
EA200000468A1 (en) THERAPEUTIC COMPOSITION FOR THE ADMINISTRATION OF TOLTERODINE WITH CONTROLLED DELIVERY
AU4722785A (en) Initiating reperfusion treatment when heart attack symptoms are present
KR900701282A (en) Treatment, prevention of ischemic diseases of the heart or brain
KR890012666A (en) Treatment of Kidney Disease
US3888977A (en) Modified neurotoxin
HK1037142A1 (en) Phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate for the treatment of neoplastic diseases
DK0668077T3 (en) Products containing G-CSF and TNF-binding protein
AU6069794A (en) Method and compositions for noninvasive dose to effect administration of lipophilic drugs
RU96117516A (en) METHOD FOR TREATING PRE- AND PROLIFERATIVE DIABETIC RETINOPATHY
ATE86112T1 (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF INFLAMMATED NOSE MUCOUS.
EP0397211A3 (en) Percutaneous administration of 3'-azide-3'-deoxythymidine
RU95113855A (en) METHOD FOR CONSERVATIVE TREATMENT OF EYE BURNS
RU95108457A (en) Method of treatment of severe forms of glps
RU97111211A (en) METHOD FOR TREATING PATIENTS WITH SURGICAL ENDOTOXICOSIS
RU96117517A (en) METHOD FOR TREATING DIABETIC RETINOPATHY
KR890001555A (en) Uric acid excretion composition
RU94013606A (en) Hemostimulator
RU93021719A (en) METHOD OF TREATMENT OF THE RETINA
RU2000101091A (en) METHOD FOR TREATING DYSTROPHIC DISEASES OF THE RETAIL AND VISUAL NERVE
RU95100951A (en) Method of treatment of male sterility
RU98102832A (en) METHOD FOR TREATMENT OF RECURRENT HEMOPHTHALMIS AND Edematous hemorrhagic forms of diabetic retinopathy
RU97115937A (en) USE OF ISOSORBIDE-5-MONONITRATE
RU96115219A (en) METHOD FOR TREATING PATIENTS WITH SUGAR DIABETES